May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension

Thomas Beaney(Imperial College London), Mir Ishraquzzaman, Ruan Kruger(South African Medical Research Council), Mohammad Al Mamun(Sylhet Agricultural University), Dorairaj Prabhakaran(Dignity Health), Fazila‐Tun‐Nesa Malik(National Heart Foundation Hospital & Research Institute), Rhian M. Touyz(McGill University Health Centre), Ella Niederl, Kamsar Yu Babinyan, Rudina Cunashi, Arsen Minasyan, Genc Burazeri(University of Medicine Tirana), P. Rodríguez Carnero, Michael A. Weber(SUNY Downstate Health Sciences University), Maciej Tomaszewski(University of Manchester), Markus P. Schlaich(The University of Western Australia), Rafael R. Castillo(Davao Doctors Hospital), Fadi J. Charchar(Federation University), Aletta E. Schutte(The George Institute for Global Health), Gentiana Qirjako, Yamila Cerniello, M. Carrington(Baker Heart and Diabetes Institute), Neil R Poulter(Imperial College London), Sohel Reza Choudhury(Shiga University of Medical Science), Louise M. Burrell(Austin Health), James E. Sharman(University of Tasmania), Suzie Cro(Imperial College London), Walter G. Espeche, Sabine Perl, Revathy Carnagarin, Albertino Damasceno(Universidade do Porto), Diego Stisman, Enver Roshi, Rebecca Lee(Broughton Hospital), Ji-Guang Wang(Shanghai Institute of Hypertension), Peter M Nilsson(Lund University), Mario J C C Fernandes, Marisa F M P Neto, Ana C G Feijão, Fortunato García Vásquez, Juith M Zilberman, Marcos J. Marín, A. Gevorkyan, Agustín J. Ramiréz(Favaloro Foundation), Inés A Fuentes, Savarino S Victória Pereira, Anna H Engibaryan, Pombalino N M Oliveira, Avag Avagyan
European Heart Journal
April 25, 2019
10.1093/eurheartj/ehz300
Cited by 269

Related Papers

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
|The Lancet|2021|3.8k
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
|The Lancet|2003|3.8k
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
|The Lancet|2005|2.9k
Hemodynamic Patterns of Age-Related Changes in Blood Pressure
|Circulation|1997|2.3k